Estimating the economic costs of antimicrobial resistance: Model and Results
RAND Corporation eBooks2014
Citations Over TimeTop 1% of 2014 papers
Jirka Taylor, Marco Hafner, Erez Yerushalmi, Richard S. Smith, Jacopo Bellasio, Raffaele Vardavas, Teresa Bienkowska-Gibbs, Jennifer Rubin
Abstract
The independent Review on AMR led by the economist Jim O'Neill commissioned RAND Europe to conduct a study estimating the global costs of antimicrobial resistance until 2050 in the absence of any progress in tackling the challenge.
Related Papers
- Analysis of the Antimicrobial Activity of Antimicrobial Peptides Extracted from Immunized Tenebrio molitor Induced by Different Microbial Treatments Against 26 Pathogens(2010)
- Antimicrobial activity of Gemini antimicrobial agents with different chemical structure(2008)
- Antimicrobial Activity of the Antimicrobial Peptides Extracted from Immunized Tenebrio molitor Induced by Different Microbial Treatments Against 26 Pathogens(2011)
- Investigation of Antimicrobial Applications in 1780 Discharged Patients(2006)
- Investigation and management of antimicrobial agents usage(2003)